John P. Sharp
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John P. Sharp
Earlier roles on record: CFO at Skye Bioscience, Inc. (SKYE) until September 8, 2026. Skye Bioscience, Inc. reported in an 8-K filed September 11, 2026 that John P. Sharp resigned as Chief Financial Officer and principal financial and accounting officer, effective September 8, 2026. Skye Bioscience, Inc. reported in an 8-K filed April 3, 2026 that John P. Sharp was appointed Chief Financial Officer, effective March 31, 2026.
“On September 8, 2026, John P. Sharp resigned as Chief Financial Officer and principal financial and accounting officer of the Company, effective as of the Effective Date.”
“On March 31, 2026, the Board appointed John P. Sharp as the Chief Financial Officer of the Company ("CFO"), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2026-09-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.